Literature DB >> 16920914

EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity.

Hongsheng Wang1, Matilda W Nicholas, Kara L Conway, Pradip Sen, Ramiro Diz, Roland M Tisch, Stephen H Clarke.   

Abstract

EBV is associated with systemic lupus erythematosus (SLE), but how it might contribute to the etiology is not clear. Since EBV-encoded latent membrane protein 2A (LMP2A) interferes with normal B cell differentiation and function, we sought to determine its effect on B cell tolerance. Mice transgenic for both LMP2A and the Ig transgene 2-12H specific for the ribonucleoprotein Smith (Sm), a target of the immune system in SLE, develop a spontaneous anti-Sm response. LMP2A allows anti-Sm B cells to overcome the regulatory checkpoint at the early preplasma cell stage by a self-Ag-dependent mechanism. LMP2A induces a heightened sensitivity to TLR ligand stimulation, resulting in increased proliferation or Ab-secreting cell differentiation or both. Thus, we propose a model whereby LMP2A induces hypersensitivity to TLR stimulation, leading to activation of anti-Sm B cells through the BCR/TLR pathway. These data further implicate TLRs in the etiology of SLE and suggest a mechanistic link between EBV infection and SLE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920914     DOI: 10.4049/jimmunol.177.5.2793

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

2.  Blimp-1-dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses.

Authors:  Andrea M Siegel; Udaya Shankari Rangaswamy; Ruth J Napier; Samuel H Speck
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

3.  Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity.

Authors:  Jennifer D Larson; Joshua M Thurman; Anatoly V Rubtsov; David Claypool; Philippa Marrack; Linda F van Dyk; Raul M Torres; Roberta Pelanda
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

4.  [Autoreactivity in B cell development].

Authors:  M P Bach; D Schneider; H Jumaa
Journal:  Z Rheumatol       Date:  2014-02       Impact factor: 1.372

5.  Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c⁺ B-cell population is important for the development of autoimmunity.

Authors:  Anatoly V Rubtsov; Kira Rubtsova; Aryeh Fischer; Richard T Meehan; Joann Z Gillis; John W Kappler; Philippa Marrack
Journal:  Blood       Date:  2011-05-04       Impact factor: 22.113

6.  Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis.

Authors:  R Bultema; R Longnecker; M Swanson-Mungerson
Journal:  Oncogene       Date:  2009-02-02       Impact factor: 9.867

7.  The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling.

Authors:  Masato Ikeda; Richard Longnecker
Journal:  Virology       Date:  2008-12-10       Impact factor: 3.616

8.  EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.

Authors:  Ilaria Guasparri; Darya Bubman; Ethel Cesarman
Journal:  Blood       Date:  2008-01-29       Impact factor: 22.113

9.  Receptor cross-talk spatially restricts p-ERK during TLR4 stimulation of autoreactive B cells.

Authors:  Sang-Ryul Lee; Jennifer A Rutan; Andrew J Monteith; Shannon Z Jones; Sun Ah Kang; Kristen N Krum; Michelle A Kilmon; Jose R Roques; Nikki J Wagner; Stephen H Clarke; Barbara J Vilen
Journal:  J Immunol       Date:  2012-09-14       Impact factor: 5.422

10.  Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.

Authors:  Heather J Martin; Jae Myun Lee; Dermot Walls; S Diane Hayward
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.